Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma
21 juin 2021 08h30 HE | Auris Medical AG
Treatment with OligoPhoreTM siRNA stops aggressive ATLL tumor growth to near zeroSignificant reduction in tumor size, spleen size and peripheral blood lymphocyte countsResults add to extensive body of...
Auris Medical Provides Update on Bentrio Program in Allergy
07 mai 2021 09h05 HE | Auris Medical AG
BentrioTM meets primary efficacy endpoint in clinical evaluation in allergic rhinitisClinically relevant and significant reduction in nasal symptomsSuperior efficacy ratings by patients and clinicians...
Vision Service Plan logo
Employers Offering Vision Insurance Save $5.8 Billion on Healthcare
03 févr. 2014 09h10 HE | Vision Service Plan
RANCHO CORDOVA, Calif., Feb. 3, 2014 (GLOBE NEWSWIRE) -- A recent study conducted by HCMS Group, a human capital risk management firm that analyzes data to help employers reduce waste in health...